Morales-Blanhir JE, Sierra-Lara-Martínez JD, Rosas-Romero MJ

Idioma: Español
Referencias bibliográficas: 26
Paginas: 35-41
Archivo PDF: 419.40 Kb.

RESUMEN

La tromboembolia pulmonar es una enfermedad común y una de las principales causas de muerte. El tromboembolismo pulmonar masivo requiere un abordaje e intervención terapéutica agresivos y oportunos. La tromboembolia pulmonar aguda asociada a inestabilidad hemodinámica (choque o hipotensión arterial) tiene un riesgo alto de mortalidad (25-65%) en las primeras horas, y hasta el 10% de riesgo de progresar a choque cardiogénico; se estima que hasta en el 50% de los casos esta se asocia a tromboembolia pulmonar recurrente. El tratamiento que con base en la evidencia ha demostrado mejoría clínica y disminución en el riesgo de mortalidad es la anticoagulación. Sin embargo, existen condiciones clínicas en las que el inicio de esta terapia puede estar contraindicado; es decir, deberán considerarse otras opciones terapéuticas. Al presente, no existe evidencia concreta en base a estudios clínicos, de la utilidad de las opciones alternas que sean comparables con la anticoagulación, en el tratamiento de la tromboembolia pulmonar; se discuten las distintas opciones disponibles en tromboembolia pulmonar aguda.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med 2003;163:1711-1717.

2. Konstantinides S. Clinical acute pulmonary embolism. N Engl J Med 2008;359:2804-2813.

3. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008;29:2276-2315.

4. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 2012;379:1835-1846.

5. Uflacker R. Interventional therapy for pulmonary embolism. J Vasc Interv Radiol 2001;12:147-164.

6. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997;30:1165-1171.

7. Chung J, Owen RJ. Using inferior vena cava filters to prevent pulmonary embolism. Can Fam Physician 2008;54:49e-55e.

8. Jaff MR, McMurtry MS, Archer LA, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011;123:1788-830.

9. White RH, Zhou H, Kim J, Romano PS. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med 2000;160:2033-2041.

10. Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pulmonary embolism. Circulation 2006;113:577-582.

11. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):7S-47S.

12. Tapson VF. Interventional therapies for venous thromboembolism: vena cava interruption, surgical embolectomy, and catheter-directed interventions. Clin Chest Med 2010;31:771-781.

13. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis: Prévention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998;338:409-415.

14. Gulba DC, Schmid C, Borst HG, Lichtlen P, Dietz R, Luft FC. Medical compared with surgical treatment for massive pulmonary embolism. Lancet 1994;343:576-577.

15. Aklog L, Williams CS, Byrne JG, Goldhaber SZ. Acute pulmonary embolectomy: a contemporary approach. Circulation 2002;105:1416-1419.

16. Kucher N. Catheter embolectomy for acute pulmonary embolism. Chest 2007;132:657-663.

17. Verstraete M, Miller GA, Bounameaux H, et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988;77:353-360.

18. Eid-Lidt G, Gaspar J, Sandoval J, et al. Combined clot fragmentation and aspiration in patients with acute pulmonary embolism. Chest 2008;134:54-60.

19. Greenfield LJ, Proctor MC, Williams DM, Wakefield TW. Long-term experience with transvenous catheter pulmonary embolectomy. J Vasc Surg 1993;18:450-457.

20. Schmitz-Rode T, Janssens U, Duda SH, Erley CM, Günther RW. Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter. J Am Coll Cardiol 2000;36:375-380.

21. Kuo WT, van den Bosch MA, Hofmann LV, Louie JD, Kothary N, Sze DY. Catheter-directed embolectomy, fragmentation, and thrombolysis for the treatment of massive pulmonary embolism after failure of systemic thrombolysis. Chest 2008;134:250-254.

22. Kuo WT. Endovascular therapy for acute pulmonary embolism. J Vasc Interv Radiol 2012;23:167-179.

23. Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation 2005;112:e28-e32.

24. De Gregorio MA, Gimeno MJ, Mainar A, et al. Mechanical and enzymatic thrombolysis for massive pulmonary embolism. J Vasc Interv Radiol 2002;13(2 Pt 1):163-169.

25. Kucher N, Windecker S, Banz Y, et al. Percutaneous catheter thrombectomy device for acute pulmonary embolism: in vitro and in vivo testing. Radiology 2005;236:852-858.

26. Danetz JS, McLafferty RB, Ayerdi J, et al. Pancreatitis caused by rheolytic thrombolysis: an unexpected complication. J Vasc Interv Radiol 2004;15: 857-860.